Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
IEU | Ann: COMPONENTS OF DISTRIBUTIONS | 08/07/25 | 0 | 104 | |||
|
|||||||
IEU | Ann: NUMBER OF OUTSTANDING UNITS AND FUND FLOWS | 07/07/25 | 0 | 122 | |||
|
|||||||
IEU | Ann: DISTRIBUTION REINVESTMENT PLAN PRICES | 01/07/25 | 0 | 97 | |||
|
|||||||
IEU | Ann: FINAL DISTRIBUTION ANNOUNCEMENT | 01/07/25 | 0 | 73 | |||
|
|||||||
IEU | Ann: ESTIMATED DISTRIBUTION | 27/06/25 | 0 | 141 | |||
|
|||||||
IEU | Ann: DISTRIBUTION DATES | 20/06/25 | 0 | 209 | |||
|
|||||||
IEU | Ann: PRODUCT DISCLOSURE STATEMENT | 11/06/25 | 0 | 118 | |||
|
|||||||
IEU | Ann: NUMBER OF OUTSTANDING UNITS AND FUND FLOWS | 06/06/25 | 0 | 147 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |